Li, Hui
Zhu, Yitan
Burnside, Elizabeth S
Huang, Erich
Drukker, Karen
Hoadley, Katherine A
Fan, Cheng
Conzen, Suzanne D
Zuley, Margarita
Net, Jose M
Sutton, Elizabeth
Whitman, Gary J
Morris, Elizabeth
Perou, Charles M
Ji, Yuan
Giger, Maryellen L
Article History
Received: 4 August 2015
Revised: 22 February 2016
Accepted: 1 April 2016
First Online: 11 May 2016
Competing interests
: M.L.G. is a stockholder in R2 technology/Hologic and receives royalties from Hologic, GE Medical Systems, MEDIAN Technologies, Riverain Medical, Mitsubishi and Toshiba. She is a cofounder of and stockholder in Quantitative Insights. K.D., and H.L. receives royalties from Hologic. C.M.P. is an equity stock holder, and Board of Director Member, of Bioclassifier, LLC. C.M.P. is also listed as an inventor on a patent application on the PAM50 assay. M.L.G., and H.L. were responsible for the computer analysis of the TCIA images; E.S.B., M.Z., J.M.N., E.S., G.J.W., E.M., E.B., K.B., B.D., M.G., and H.L.P. were responsible for acquiring the lesion locations in the TCIA MRIs; C.M.P., K.A.H., and C.F. were responsible for the assessment of the molecular subtyping of the breast cancer lesions from the TCGA; M.L.G., H.L., Y.Z., K.D., E.S.B., S.D.C., E.M., and Y.J. were involved in the analytic concept and design; M.L.G., H.L., K.D., and E.H. contributed to the statistical analyses; all authors participated in the manuscript preparation, the interpretation of data analysis results, and critical review/revision of the manuscript for important intellectual content. All authors read and approved the final manuscript. All authors agreed to be accountable for all aspects of the work.